Vaccine against Ebola: Commission grants first-ever market authorisation
Date of publication: 12-11-2019
The European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against Ebola. This vaccine, called Ervebo, had been in development since the Ebola outbreak in West Africa in 2014. Źródło: https://ec.europa.eu
